Document is current

Any future updates will be listed below

Correction: Efficacy of Nirmatrelvir/ritonavir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case–control study (SAVALO Study)

Crossref DOI link: https://doi.org/10.1186/s12879-025-11043-w

Published Online: 2025-04-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark